Fintel reports that on March 14, 2025, Citizens Capital Markets upgraded their outlook for Allogene Therapeutics ...
Fintel reports that on March 14, 2025, Citizens Capital Markets downgraded their outlook for Sutro Biopharma (NasdaqGM:STRO) ...
Morgan Stanley anticipates that a slow start to the capital markets this year will push a rebound in activity into coming ...